Technical Analysis for INSY - Insys Therapeutics, Inc.
|Grade||Last Price||% Change||$ Change|
INSY closed up 2.66 percent on Monday, February 27, 2017, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Trend Table & Recent Alerts
|See historical INSY trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 27||NR7||Range Contraction||0.00%|
|Feb 27||Calm After Storm||Range Contraction||0.00%|
|Feb 24||New Uptrend||Bullish||2.66%|
|Feb 24||Upper Bollinger Band Walk||Other||2.66%|
|Feb 24||Slingshot Bullish||Bullish Swing Setup||2.66%|
|Feb 24||Calm After Storm||Range Contraction||2.66%|
|Feb 23||Downside 200 DMA Break||Bearish||-3.52%|
|Feb 23||Stochastic Sell Signal||Bearish||-3.52%|
|Feb 23||Upper Bollinger Band Walk||Other||-3.52%|
|Feb 22||Upside 200 DMA Break||Bullish||-8.38%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The companys cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more INSY news...
|52 Week High||21.22|
|52 Week Low||8.7|
|200-Day Moving Average||12.89|
|50-Day Moving Average||10.17|
|20-Day Moving Average||10.71|
|10-Day Moving Average||11.51|
|Average True Range||0.73|
|Chandelier Exit (Long, 3 ATRs)||11.5|
|Chandelier Exit (Short, 3 ATRs)||11.49|
|Upper Bollinger Band||13.15|
|Lower Bollinger Band||8.27|
|Percent B (%b)||0.84|